Benzinga | Mar 15, 2021 06:32AM EDT

Beam Therapeutics Q4 EPS $(1.69), Sales $6.00K

Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(1.69) per share. The company reported $6.00 thousand in sales this quarter.